Showing 1-10 of 28 results for "".
- Biosimilar News: YUFLYMA Added to CarePartners Specialty Pharmacy Cost Savings Programshttps://practicaldermatology.com/news/biosimilar-news-yuflyma-added-to-carepartners-specialty-pharmacy-cost-savings-programs/2462100/Celltrion USA, Inc.’s US Food and Drug Administration-approved biosimilar, YUFLYMA (adalimumab-aaty) has been added to CarePartners Specialty Pharmacy Cost Savings Programs. YUFLYMA is a high-concentration (100mg/mL) and citrate-free formulation of the Humira (adalimumab) biosimilar. CarePartners…
- Shin Young Yuhttps://practicaldermatology.com/profiles/shin-young-yu/LgvgwY/
- Impact of Alopecia Areata on Pediatric Patients and Their Families: Insights from a Single-Center Study in Turkeyhttps://practicaldermatology.com/news/impact-alopecia-areata-pediatric-patients-and-their-families-insights-single-center-study-turkey/2462829/Alopecia areata (AA) is known to impact the health-related quality of life (HRQoL) of affected individuals, yet there is a paucity of research focusing on its effects specifically in pediatric patients and their families. To address this gap, researchers recently conducted a single-center cross-sec…
- Top Non-cosmetic Laser Indications Vary by Laser Typehttps://practicaldermatology.com/news/top-non-cosmetic-laser-indications-vary-laser-type/2462734/Treatment of psoriasis, vascular lesions, and hypertrophic disorders were the most common non-cosmetic indications for dermatologic use of excimer, vascular, and ablative lasers, respectively, based on data from more than 55,000 individuals. Non-cosmetic laser therapy in dermatology has experiencin…
- Topical Steroids and Bone Healthhttps://practicaldermatology.com/news/topical-steroids-and-bone-health/2462197/Recently released study data found that higher doses of topical corticosteroids, such as those often used to treat inflammatory skin disorders, are tied to increased risks for osteoporosis and bone fractures associated with osteoporosis. Based on data from the Taiwan National Health Insurance Resea…
- How Does Social Media Influence Patients’ Understanding of Dermatologic Information?https://practicaldermatology.com/news/examining-social-medias-influence-on-patients-understanding-of-dermatologic-information/2462143/Social media users trust what’s out there about dermatologic conditions and make healthcare decisions based on this information for better or for worse, according to research presented at the 2nd Annual Dermatology Therapeutics Symposium (DTS) in Austin, Texas. “Healthcare professionals have a crit…
- Super Melanin May Heal Skin Injuries From Sunburn, Chemical Burnshttps://practicaldermatology.com/news/super-melanin-may-heal-skin-injuries-from-sunburn-chemical-burns/2462125/A synthetic, biomimetic melanin may heal the damage that occurs when your skin is exposed to sunlight or environmental toxins. In a new study, Northwestern University scientists show that their synthetic melanin, mimicking the natural melanin in human skin, can be applied topically to injured skin…
- Practical Considerations in Pediatric Alopeciahttps://practicaldermatology.com/news/practical-considerations-in-pediatric-alopecia/2461950/Hair loss in children encompasses a wide spectrum of conditions that may be congenital or acquired. Hair consists of the proteinaceous shaft and the root, anchored in the follicle, an involution of the epidermis.1 Newborn follicles produce soft lanugo hair, which is replaced by downy, fine vellus h…
- Inmagene's OX40 mAb Enters POC Study in ADhttps://practicaldermatology.com/news/inmagenes-ox40-mab-enters-poc-study-in-ad/2461934/The first patient has been dosed in a global multicenter proof-of-concept (POC) study of Inmagene Biopharmaceuticals’ IMG-007 in adults with moderate-to-severe atopic dermatitis (AD). The objective of the study is to assess the safety, pharmacokinetics, and efficacy of IMG-007 in AD patients. I…
- Research Closes in on the Genetic Factors Underlying HS Riskhttps://practicaldermatology.com/news/research-closes-in-on-the-genetic-factors-underlying-hs-risk/2461893/Researchers have identified genetic locations for increased risk of hidradenitis suppurativa (HS). “This discovery is highly relevant because these changes may effect nearby genes in a way that leads to improper development of hair follicles and predispose them to the rupture,” says study author …
- Prev
- Next